| EPB0150 | 24 week efficacy and safety of efavirenz- and dolutegravir-based antiretroviral therapy with isoniazid and rifapentine for tuberculosis preventive therapy (1HP and 3HP) in Thai people living with HIV | E-poster | Co-infections (including opportunistic infections) |
| EPB0151 | Hepatitis delta and liver disease among people living with hepatitis B in Senegal | E-poster | Co-infections (including opportunistic infections) |
| EPB0152 | Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal: 1-year results of a prospective cohort study | E-poster | Co-infections (including opportunistic infections) |
| EPB0153 | Drug Resistant Tuberculosis (DR-TB) detection among new, previously treated TB cases, and people living with HIV in Western and Southern highlands, Tanzania | E-poster | Co-infections (including opportunistic infections) |
| EPB0154 | Finding missing tuberculosis (TB) cases in Ugandan military health facilities through use of mobile digital X-ray services and technology (Mobile TB Clinics) | E-poster | Co-infections (including opportunistic infections) |
| EPB0155 | Readiness for HCV care provision for men who have sex with men in seven countries | E-poster | Co-infections (including opportunistic infections) |
| EPB0156 | Decrease of Yellow Fever neutralizing antibody titers one year after vaccination is related to different NK cells repertoire in PLWH and non-HIV controls - ANRS12403 | E-poster | Co-infections (including opportunistic infections) |
| EPB0157 | Health system strengthening approach improves national TB preventive therapy (TPT) coverage in Malawi | E-poster | Co-infections (including opportunistic infections) |
| EPB0158 | Incidence of occult hepatitis B virus among people living with HIV in Botswana | E-poster | Co-infections (including opportunistic infections) |
| EPB0159 | Changes in symptoms of depression and anxiety over time in a cohort of people with HIV initiating HIV care in Cameroon | E-poster | Co-morbidities |